ES2112994T3 - Analogos de clomifeno no metabolizables utilizados en el tratamiento de tumores resistentes al tamoxifeno. - Google Patents

Analogos de clomifeno no metabolizables utilizados en el tratamiento de tumores resistentes al tamoxifeno.

Info

Publication number
ES2112994T3
ES2112994T3 ES93920100T ES93920100T ES2112994T3 ES 2112994 T3 ES2112994 T3 ES 2112994T3 ES 93920100 T ES93920100 T ES 93920100T ES 93920100 T ES93920100 T ES 93920100T ES 2112994 T3 ES2112994 T3 ES 2112994T3
Authority
ES
Spain
Prior art keywords
tamoxifeno
clomifene
treatment
resistant tumors
analogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93920100T
Other languages
English (en)
Inventor
Alan J Bitonti
Russell J Baumann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2112994T3 publication Critical patent/ES2112994T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/45—Monoamines
    • C07C211/48—N-alkylated amines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

COMPUESTOS DE FORMULA (I) EN DONDE R1 Y R2 SON CADA UNO SELECCIONADOS DEL GRUPO QUE CONSISTE DE ALQUILO INFERIOR C1-C4; X ES NH O S; Y N ES UN NUMERO ENTERO DENTRO DEL MARGEN DE 1-4 INCLUSIVES; Y CUANDO N = 0, X ES (CH2)3 Y LAS SALES FARMACEUTICAMENTE ACEPTABLES DE ELLOS HAN DEMOSTRADO SER EFECTIVOS EN TRATAMIENTO DE TUMORES RESISTENTES A TAMOXIFENO.
ES93920100T 1992-09-15 1993-08-16 Analogos de clomifeno no metabolizables utilizados en el tratamiento de tumores resistentes al tamoxifeno. Expired - Lifetime ES2112994T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94530592A 1992-09-15 1992-09-15

Publications (1)

Publication Number Publication Date
ES2112994T3 true ES2112994T3 (es) 1998-04-16

Family

ID=25482938

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93920100T Expired - Lifetime ES2112994T3 (es) 1992-09-15 1993-08-16 Analogos de clomifeno no metabolizables utilizados en el tratamiento de tumores resistentes al tamoxifeno.

Country Status (16)

Country Link
US (2) US5410080A (es)
EP (1) EP0660821B1 (es)
JP (1) JPH09500863A (es)
KR (1) KR100326962B1 (es)
AT (1) ATE162516T1 (es)
AU (1) AU672234B2 (es)
CA (1) CA2143000C (es)
DE (1) DE69316633T2 (es)
DK (1) DK0660821T3 (es)
ES (1) ES2112994T3 (es)
FI (1) FI951193A (es)
GR (1) GR3026236T3 (es)
HU (1) HUT71244A (es)
NO (1) NO950985D0 (es)
NZ (1) NZ255785A (es)
WO (1) WO1994006762A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR008155A1 (es) * 1996-09-06 1999-12-09 Smithkline Beecham Corp Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres.
NZ502738A (en) 1997-08-15 2002-06-28 Univ Duke Triphenylethylene derivatives similar to tamoxifen or toremifene derivatives
UA113291C2 (xx) * 2011-08-04 2017-01-10 Метаболіти транскломіфену і їх застосування
US9687458B2 (en) 2012-11-02 2017-06-27 Repros Therapeutics Inc. Trans-clomiphene for use in cancer therapy
JP2017507961A (ja) 2014-03-11 2017-03-23 レプロス セラピューティクス インコーポレイティド 単一の溶媒を用いるクロミフェン合成

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2750416A (en) * 1950-12-21 1956-06-12 Rohm & Haas Aminomethylphenols and method for their preparation
US3143568A (en) * 1961-01-25 1964-08-04 Vismara Francesco Spa Diarylamino-acetyl-aryl derivatives
US3244705A (en) * 1962-11-14 1966-04-05 Richardson Merrell Inc Triphenylhaloethylene derivatives
CH373975A (de) * 1963-07-20 1963-12-15 Heierle Werner Kronen-Verschluss für Flaschen
FR3575M (fr) * 1964-01-28 1965-10-04 Richardson Merrell Triphénylhalogénoéthylenes substitués.
US3631109A (en) * 1968-12-04 1971-12-28 Uniroyal Inc Beta beta'-bis(dialkylaminomethyl-4-hydroxy-benzylthio)dialkylethers
GB2126576B (en) * 1982-06-25 1985-06-19 Farmos Group Limited Alkane and alkene derivatives
EP0260066B1 (en) * 1986-09-11 1990-05-09 National Research Development Corporation Tamoxifen derivatives
US5114951A (en) * 1989-04-11 1992-05-19 Burroughs Wellcome Company Agents for combating multiple drug resistance
US5130424A (en) * 1990-08-01 1992-07-14 Merrell Dow Pharmaceuticals Inc. 4-amino-delta-4,6-steroids and their use as 5 alpha-reductase inhibitors

Also Published As

Publication number Publication date
DE69316633T2 (de) 1998-05-20
US5410080A (en) 1995-04-25
FI951193A0 (fi) 1995-03-14
JPH09500863A (ja) 1997-01-28
HUT71244A (en) 1995-11-28
DE69316633D1 (de) 1998-02-26
EP0660821B1 (en) 1998-01-21
GR3026236T3 (en) 1998-05-29
HU9500775D0 (en) 1995-05-29
EP0660821A1 (en) 1995-07-05
AU672234B2 (en) 1996-09-26
DK0660821T3 (da) 1998-09-21
AU5015093A (en) 1994-04-12
CA2143000A1 (en) 1994-03-31
ATE162516T1 (de) 1998-02-15
NO950985L (no) 1995-03-14
NZ255785A (en) 1997-05-26
FI951193A (fi) 1995-03-14
CA2143000C (en) 2000-03-28
US5681863A (en) 1997-10-28
NO950985D0 (no) 1995-03-14
WO1994006762A1 (en) 1994-03-31
KR950703524A (ko) 1995-09-20
KR100326962B1 (ko) 2002-12-02

Similar Documents

Publication Publication Date Title
CO4410321A1 (es) Compuestos ciclicos condensados con funciones aminoacidas sustituidas y derivados ester de los mismos
ATE94065T1 (de) Diazepine enthaltende pharmazeutische zusammensetzungen mit plaettchen aktivierender faktor (paf)-antagonistischer wirkung.
ES2121988T3 (es) Derivado de morfinano y uso medicinal.
ES8605821A1 (es) Un procedimiento para la preparacion de aciltripeptidos in- munoestimulantes
ES2124545T3 (es) Azolidindionas como agentes antihiperglucemicos.
DE69115297D1 (de) Leukotrien-b4-antagonisten.
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
DK0482071T3 (da) Nye antivirale midler
ES2112994T3 (es) Analogos de clomifeno no metabolizables utilizados en el tratamiento de tumores resistentes al tamoxifeno.
ES8106903A1 (es) Procedimiento de preparar compuestos de acido benzo(ij)qui- nolicin-2-carboxilico
ATE188217T1 (de) 1,2,3,4,10,14b-hexahydrodibenzo-c,f)pyrazino-1, - a)azepino-derivate
ES8303316A1 (es) Un procedimiento para la fabricacion de un disulfuro intra ointermolecular
ES2003086A6 (es) Procedimiento de obtencion de tienoquinolicinsulfonamidas
ES8605803A1 (es) Procedimiento para la fabricacion de nuevos compuestos cina-moicos
SE7412163L (es)
ES8106147A1 (es) Procedimiento para preparar un 1,2,4-triazol-3-tiol
EA199700200A1 (ru) Способы ингибирования рака яичника
ES2006099A6 (es) Procedimiento para la obtencion de hidrocloruro de ciprofloxacina monohidrato.
ES8306154A1 (es) "procedimiento para la preparacion de nuevas 6 -metoxi-penicilinas".
PH23966A (en) Imidazoquinozoline compounds as agent for treatment of nephritis
ES2120039T3 (es) Nuevos acildipeptidos heterociclicos, procedimientos de preparacion y composiciones farmaceuticas que los contienen.
JPS5636414A (en) Anticonvulsant agent containing omega-aminoalkoxystilbene or its acid addition salt as active constituent
JPS5430169A (en) 2-aminoalkyl-5-phenyloxazoles and their pharmaceutically acceptable aicd salts
IT1247932B (it) Composti ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 660821

Country of ref document: ES